<?xml version="1.0" encoding="UTF-8"?><!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1d3 20150301//EN"  "JATS-archivearticle1.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3"><front><journal-meta><journal-id journal-id-type="nlm-ta">elife</journal-id><journal-id journal-id-type="publisher-id">eLife</journal-id><journal-title-group><journal-title>eLife</journal-title></journal-title-group><issn publication-format="electronic">2050-084X</issn><publisher><publisher-name>eLife Sciences Publications, Ltd</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">84815</article-id><article-id pub-id-type="doi">10.7554/eLife.84815</article-id><article-categories><subj-group subj-group-type="display-channel"><subject>Research Article</subject></subj-group><subj-group subj-group-type="heading"><subject>Genetics and Genomics</subject></subj-group><subj-group subj-group-type="heading"><subject>Microbiology and Infectious Disease</subject></subj-group></article-categories><title-group><article-title>The mutational signatures of poor treatment outcomes on the drug-susceptible <italic>Mycobacterium tuberculosis</italic> genome</article-title></title-group><contrib-group><contrib contrib-type="author" id="author-299163"><name><surname>Chen</surname><given-names>Yiwang</given-names></name><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231014"><name><surname>Jiang</surname><given-names>Qi</given-names></name><xref ref-type="aff" rid="aff2">2</xref><xref ref-type="other" rid="par-2"/><xref ref-type="other" rid="par-4"/><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-299164"><name><surname>Peierdun</surname><given-names>Mijiti</given-names></name><xref ref-type="aff" rid="aff3">3</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" id="author-231022"><name><surname>Takiff</surname><given-names>Howard E</given-names></name><xref ref-type="aff" rid="aff4">4</xref><xref ref-type="fn" rid="conf1"/></contrib><contrib contrib-type="author" corresp="yes" id="author-231024"><name><surname>Gao</surname><given-names>Qian</given-names></name><contrib-id contrib-id-type="orcid">http://orcid.org/0000-0002-8489-3672</contrib-id><xref ref-type="aff" rid="aff1">1</xref><xref ref-type="corresp" rid="cor1">*</xref><xref ref-type="other" rid="par-1"/><xref ref-type="other" rid="par-3"/><xref ref-type="fn" rid="conf1"/></contrib><aff id="aff1"><institution content-type="dept">School of Basic Medical Sciences</institution>, <institution>Fudan University</institution>, <addr-line><named-content content-type="city">Shanghai</named-content></addr-line>, <country>China</country></aff><aff id="aff2"><institution content-type="dept">School of Public Health</institution>, <institution>Wuhan University</institution>, <addr-line><named-content content-type="city">Wuhan</named-content></addr-line>, <country>China</country></aff><aff id="aff3"><institution content-type="dept">Department of Epidemiology and Biostatistics</institution>, <institution>Xinjiang Medical University</institution>, <addr-line><named-content content-type="city">Urumqi</named-content></addr-line>, <country>China</country></aff><aff id="aff4"><institution>Instituto Venezolano de Investigaciones Cientificas</institution>, <addr-line><named-content content-type="city">Caracas</named-content></addr-line>, <country>Venezuela</country></aff></contrib-group><contrib-group content-type="section"><contrib contrib-type="editor" id="author-56267"><name><surname>Kana</surname><given-names>Bavesh D</given-names></name><role>Reviewing editor</role><aff><institution>University of the Witwatersrand</institution>, <country>South Africa</country></aff></contrib></contrib-group><author-notes><corresp id="cor1"><label>*</label>For correspondence: <email>qiangao@fudan.edu.cn</email> (QG);</corresp></author-notes><pub-date date-type="pub" publication-format="electronic"><day>03</day><month>05</month><year>2023</year></pub-date><volume>12</volume><elocation-id>e84815</elocation-id><history><date date-type="received"><day>09</day><month>11</month><year>2022</year></date><date date-type="accepted"><day>02</day><month>05</month><year>2023</year></date></history><permissions><copyright-statement>Â© 2023, Chen et al</copyright-statement><copyright-year>2023</copyright-year><copyright-holder>Chen et al</copyright-holder><license xlink:href="http://creativecommons.org/licenses/by/4.0/"><license-p>This article is distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0/">Creative Commons Attribution License</ext-link> permitting unrestricted use and redistribution provided that the original author and source are credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:href="elife-84815-v1.pdf"/><abstract><p>Drug resistance is a known risk factor for poor tuberculosis (TB) treatment outcomes, but the contribution of other bacterial factors to poor outcomes in drug susceptible TB is less well understood. Here, we generate a population-based dataset of drug-susceptible <italic>Mycobacterium tuberculosis</italic> (MTB) isolates from China to identify factors associated with poor treatment outcomes. We analyzed whole-genome sequencing (WGS) data of MTB strains from 3196 patients, including 3105 patients with good and 91 patients with poor treatment outcomes, and linked genomes to patient epidemiological data. A genome-wide association study (GWAS) was performed to identify bacterial genomic variants associated with poor outcomes. Risk factors identified by logistic regression analysis were used in clinical models to predict treatment outcomes. GWAS identified fourteen MTB fixed mutations associated with poor treatment outcomes, but only 24.2% (22/91) of strains from patients with poor outcomes carried at least one of these mutations. Isolates from patients with poor outcomes showed a higher ratio of reactive oxygen species (ROS)-associated mutations compared to isolates from patients with good outcomes (26.3% vs 22.9%, t test, P=0.027). Patient age, sex, and duration of diagnostic delay were also independently associated with poor outcomes. Bacterial factors alone had poor power to predict poor outcomes with an AUC of 0.58. The AUC with host factors alone was 0.70, but increased significantly to 0.74 (DeLong's test, P = 0.01) when bacterial factors were also included. In conclusion, although we identified MTB genomic mutations that are significantly associated with poor treatment outcomes in drug-susceptible TB cases, their effects appear to be limited.</p></abstract><kwd-group kwd-group-type="research-organism"><title>Research organism</title><kwd>Other</kwd></kwd-group><funding-group><award-group id="par-1"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>81661128043,81871625</award-id><principal-award-recipient><name><surname>Gao</surname><given-names>Qian</given-names></name></principal-award-recipient></award-group><award-group id="par-2"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100001809</institution-id><institution>National Natural Science Foundation of China</institution></institution-wrap></funding-source><award-id>82230078</award-id><principal-award-recipient><name><surname>Jiang</surname><given-names>Qi</given-names></name></principal-award-recipient></award-group><award-group id="par-3"><funding-source><institution-wrap><institution>Shanghai Municipal Science and Technology Major Project</institution></institution-wrap></funding-source><award-id>ZD2021CY001</award-id><principal-award-recipient><name><surname>Gao</surname><given-names>Qian</given-names></name></principal-award-recipient></award-group><award-group id="par-4"><funding-source><institution-wrap><institution-id institution-id-type="FundRef">http://dx.doi.org/10.13039/501100012226</institution-id><institution>Fundamental Research Funds for the Central Universities</institution></institution-wrap></funding-source><award-id>2042021kf0041</award-id><principal-award-recipient><name><surname>Jiang</surname><given-names>Qi</given-names></name></principal-award-recipient></award-group><funding-statement>The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.</funding-statement></funding-group></article-meta></front><back><sec id="s1" sec-type="additional-information"><title>Additional information</title><fn-group content-type="competing-interest"><title>Competing interest</title><fn fn-type="conflict" id="conf1"><p>The authors declare that no competing interests exist.</p></fn></fn-group></sec><sec id="s2" sec-type="supplementary-material"><title>Additional Files</title><sec id="s3" sec-type="data-availability"><title>Data availability</title><p>Files containing sequencing reads were deposited in the National Institutes of Health Sequence Read Archive under BioProject PRJNA869190.</p><p>The following datasets were generated:</p><p><element-citation id="dataset1" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Chen Yi</collab><collab>Jiang Q</collab><collab>Peierdun M</collab></person-group><year iso-8601-date="2022">2022</year><source>The mutational signatures of poor treatment outcomes on the drug-susceptible Mycobacterium tuberculosis genome</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA869190">https://www.ncbi.nlm.nih.gov/bioproject/?term=PRJNA869190</ext-link><comment>NCBI BioProject, PRJNA869190</comment></element-citation><element-citation id="dataset2" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Li M</collab><collab>Guo M</collab><collab>Peng Y</collab></person-group><year iso-8601-date="2022">2022</year><source>High proportion of tuberculosis transmission among social contacts in rural China: a 12-year prospective population-based genomic epidemiological study</source><ext-link ext-link-type="uri" xlink:href="https://bigd.big.ac.cn/gsa">https://bigd.big.ac.cn/gsa</ext-link><comment>PRJCA008815</comment></element-citation><element-citation id="dataset3" publication-type="data" specific-use="isSupplementedBy"><person-group person-group-type="author"><collab>Li M</collab><collab>Guo M</collab><collab>Peng Y</collab></person-group><year iso-8601-date="2022">2022</year><source>High proportion of tuberculosis transmission among social contacts in rural China: a 12-year prospective population-based genomic epidemiological study</source><ext-link ext-link-type="uri" xlink:href="https://bigd.big.ac.cn/gsa">https://bigd.big.ac.cn/gsa</ext-link><comment>PRJCA008816</comment></element-citation></p><p>The following previously published datasets were used:</p><p><element-citation id="dataset4" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Peterson EJ</collab><collab>Baliga NS</collab></person-group><year iso-8601-date="2021">2021</year><source>Mycobacterium tuberculosis transcriptional response to Isoniazid</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE165581">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE165581</ext-link><comment>GSE165581</comment></element-citation><element-citation id="dataset5" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Peterson EJ</collab><collab>Baliga NS</collab></person-group><year iso-8601-date="2021">2021</year><source>Mycobacterium tuberculosis transcriptional response to Rifampicin</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE166622">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE166622</ext-link><comment>GSE166622</comment></element-citation><element-citation id="dataset6" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Ma S</collab><collab>Lohmiller J</collab><collab>Sherman DR</collab></person-group><year iso-8601-date="2018">2018</year><source>Transcriptional Response of Mycobacterium tuberculosis H37Rv to Ethambutol</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118084">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE118084</ext-link><comment>GSE118084</comment></element-citation><element-citation id="dataset7" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Peterson EJ</collab><collab>Abidi AA</collab><collab>Baliga NS</collab></person-group><year iso-8601-date="2019">2019</year><source>Intricate genetic program underlying hypoxia-induced dormancy in Mycobacterium tuberculosis revealed by high-resolution transcriptional time-course</source><ext-link ext-link-type="uri" xlink:href="https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116353">https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE116353</ext-link><comment>GSE116353</comment></element-citation><element-citation id="dataset8" publication-type="data" specific-use="references"><person-group person-group-type="author"><collab>Guerra-AssunÃ§Ã£o J</collab><collab>Crampin A</collab><collab>Houben R</collab></person-group><year iso-8601-date="2015">2015</year><source>Large-scale whole genome sequencing of M. tuberculosis provides insights into transmission in a high prevalence area</source><ext-link ext-link-type="uri" xlink:href="https://www.ebi.ac.uk/ena/browser/home">https://www.ebi.ac.uk/ena/browser/home</ext-link><comment>ERP000436 and ERP001072</comment></element-citation></p></sec><supplementary-material><ext-link xlink:href="elife-84815-supp-v1.zip">Download zip</ext-link><p>Any figures and tables for this article are included in the PDF. The zip folder contains additional supplemental files.</p></supplementary-material></sec></back></article>